Search

IntroductionDiabetes mellitus type 2 (DM2) is a chronic metabolic disease with important repercussions in the life of the patients who suffer it. Its metabolic control is essential to reduce morbidity and mortality rates, which depends on physiological, economic, social and psychological factors. The objective of this study was to determine the association between psychological factors and metabolic control of patients with DM2.Materials and methodsThe methodological approach was descriptive cross-sectional, with analysis of cases and controls, in a group of 60 participants with diagnosis of DM2, 30 with controlled diabetes (DC) and 30 with uncontrolled diabetes (DNC); defined by the serum levels of glycosylated hemoglobin.ResultsCorrelational analysis was performed using the Spearman test, to establish the relationship between glycosylated hemoglobin and psychological variables, showing significant correlations of

Introducción: La diabetes mellitus es la patología metabólica más prevalente a nivel mundial. La “adherencia al tratamiento” es determinante en el control metabólico de la misma y se describe como la acción de involucrarse activa y voluntariamente en el manejo de la enfermedad. Objetivos: Determinar la influencia de variables neuropsicológicas y psicológicas en la adherencia al tratamiento de pacientes con diabetes tipo 2. Métodos: Se evaluaron 60 sujetos: 30 con diabetes controlada (DC) y 30 con diabetes no controlada (DNC), remitidos por centros diabetologícos en la ciudad de Barranquilla, entre julio y noviembre de 2015, a los cuales se les realizó evaluación neuropsicológica, de percepción de salud (cuestionario de salud general de goldberg, GHQ-28) y de adherencia al tratamiento (escala de adherencia al tratamiento en diabetes mellitus tipo II: EATDM-III). El abordaje metodológico fue descriptivo transversal, con análisis de casos y controles, la selección de la muestra fue intencional no probabilística. Se utilizó la prueba de U de mann-whitney y el modelo de regresión lineal para realizar el análisis. Resultados: observamos compromiso significativo de la atención, memoria y funciones ejecutivas en los pacientes con DNC. Encontramos diferencia significativa entre ambos grupos en los puntajes de la escala (EATDM-III), en: ejercicio físico, higiene y autocuidado, dieta y valoración de la condición física. Se identificó que la variable ansiedad-insomnio tienen un riesgo de 0.771 (p=0.035), que puede influir en la adherencia al tratamiento. Conclusiones: Factores como: ejercicio físico, higiene y autocuidado, dieta y valoración de la condición física son fundamentales en el control metabólico estos pacientes. De igual manera, variables psicológicas (ansiedad-insomnio) son determinantes en la adherencia al tratamiento en este grupo de pacientes, los cuales; al ser potencialmente modificables deben ser considerados y controlados tempranamente en cualquier esquema terapéutico. Introduction: Diabetes mellitus is the most prevalent metabolic disease worldwide. “Adherence to treatment” is critical in the metabolic control of it and described as the action actively and voluntarily engages in the management of the disease. Objective: To determine the influence of neuropsychological and psychological variables in adherence to treatment of patients with type 2 diabetes. Methods: 60 subjects were evaluated: 30 with controlled diabetes (DC) and 30 with uncontrolled diabetes (DNC), submitted by centers-diabetes in the city of Barranquilla, between July and November 2015, to which underwent neuropsychological assessment, perception of health (general health questionnaire Goldberg, GHQ-28) and adherence to treatment (scale adherence treatment of type II Diabetes Mellitus: EATDMIII). The methodological approach was transversal descriptive, casecontrol analysis, selection of the sample was not probabilistic intentional. U test of Mann-Whitney and linear regression model was used to perform the analysis. Results: We observed significant commitment of attention, memory and executive functions in patients with DNC. We found a significant difference between the two groups in scores on the scale (EATDMIII), in: exercise, hygiene and selfcare, diet and fitness assessment. It was identified that anxiety-insomnia variable has a risk of 0.771 (p=0.035), which may influence adherence to treatment. Conclusions: Factors such as physical exercise, hygiene and self-care, diet and fitness assessment are fundamental in metabolic control these patients. Similarly, psychological variables (anxiety-insomnia) are determining adherence to treatment in this group of patients, which; being potentially modifiable they must be considered and controlled early in any therapeutic regimen.